Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Breast Neoplasms 9459Neoplasms 6577Prostatic Neoplasms 4394Colorectal Neoplasms 3964Lung Neoplasms 3633Carcinoma, Non-Small-Cell Lung 3576Pancreatic Neoplasms 2472Carcinoma, Hepatocellular 2407Leukemia, Myeloid, Acute 2261Multiple Myeloma 2115Stomach Neoplasms 2104Neoplasm Metastasis 1911Head and Neck Neoplasms 1864Ovarian Neoplasms 1770Precursor Cell Lymphoblastic Leukemia-Lymphoma 1732Lymphoma 1728Brain Neoplasms 1696Rectal Neoplasms 1672Melanoma 1652Colonic Neoplasms 1629Leukemia 1498Uterine Cervical Neoplasms 1493Recurrence 1480Esophageal Neoplasms 1309Glioblastoma 1303Lymphoma, Non-Hodgkin 1202Leukemia, Lymphocytic, Chronic, B-Cell 1120Squamous Cell Carcinoma of Head and Neck 1108Urinary Bladder Neoplasms 1077Lymphoma, Follicular 1067

Interventions

Oxaliplatin 2Paclitaxel 1Hyperthermic Intraperitoneal Chemotherapy 1Cytoreduction Surgical Procedures 1Bupivacaine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Peritoneal Cancer × Clear all
NCT03359811 2022-02-18

Four Quadrants Transverse Abdominus Plane (4Q-TAP) Block With Plain and Liposomal Bupivacaine vs. Thoracic Epidermal Analgesia (TEA) in Patients Undergoing Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) on an Enhanced Recovery Pathway

M.D. Anderson Cancer Center

Phase 3 Completed
75 enrolled 21 charts

Peritoneal Cancer

NCT04122885 2019-10-10

IMMUNOPAC

University Hospital Tuebingen

Unknown
60 enrolled

Peritoneal Cancer

NCT00491855 2013-01-03

Oxaliplatin and Paclitaxel Plus Bevacizumab in Advanced Peritoneal Carcinomatosis

M.D. Anderson Cancer Center

Phase 1 Completed
3 enrolled

Peritoneal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡